Concepedia
8
Publications
194
Citations
H-Index
2020
Active since
Affiliations
University of California, San Francisco(Current)
University of California System
UCSF Helen Diller Family Comprehensive Cancer Center
ProLynx (United States)
University of Virginia Medical Center
Anju Wadhwa is an author at University of California, San Francisco.
Publications per year
2020–2024
<i>In silico</i> Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19
Cheryl Sachdeva, Anju Wadhwa, Anita Kumari et al. · OMICS A Journal of Integrative Biology · 2020 · 46 citations
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
Anil P. Bidkar, Sinan Wang, Kondapa Naidu Bobba et al. · Clinical Cancer Research · 2023 · 42 citations · Full text
Evaluation of<sup>134</sup>Ce/<sup>134</sup>La as a PET Imaging Theranostic Pair for<sup>225</sup>Ac α-Radiotherapeutics
Kondapa Naidu Bobba, Anil P. Bidkar, Niranjan Meher et al. · Journal of Nuclear Medicine · 2023 · 30 citations · Full text
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma
Anju Wadhwa, Sinan Wang, Bonell Patiño-Escobar et al. · Clinical Cancer Research · 2023 · 22 citations · Full text
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5
Kondapa Naidu Bobba, Anil P. Bidkar, Anju Wadhwa et al. · Theranostics · 2024 · 18 citations · Full text
Rows per page
1–5 of 8